Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Molecular Measurable Residual Disease Detection in Acute Myeloid Leukemia Using Error Corrected Next Generation Sequencing

Nikhil Patkar, MD, Anam Fatima Shaikh, Chinmayee Kakirde, Rakhi Salve, Prasanna Bhanshe, Gaurav Chatterjee, MD, Sweta Rajpal, Swapnali Joshi, Shruti Chaudhary, Rohan Kodgule, Dhanlaxmi Lalit Shetty, PhD, Hasmukh Jain, MD, Bhausaheb Bagal, MD DM, Hari Menon, MD, Navin Khattry, MD DM, Manju Sengar, MD DM, Prashant Tembhare, MD, Papagudi Ganesan Subramanian, MD, Sumeet Gujral, MD

Blood (2020) 136 (Supplement 1): 5–6.

https://doi.org/10.1182/blood-2020-143457

Published: 2020

Journal Articles

Incidence, Risk Factors, and Outcomes of Viral Reactivations in Alternative Donor Haematopoietic Stem Cell Transplant

Vinodhini M, MDDM, Anant Gokarn, MDDM, Sachin Punatar, Sumeet Prakash Mirgh, MDDM, Akanksha Chichra, DNB, Vijay Shirure, MD DM, Avinash Bonda, MD DM, Lingaraj Nayak, MD DM, Bhausaheb Bagal, MD DM, Vivek Bhat, MD, Sanjay Biswas, MD, Sadhana Kannan, MSc, Libin J Mathew, Rachana Tripathi, Shesheer Kumar, Tapan Saikia, MD, Navin Khattry, MD DM

Blood (2020) 136 (Supplement 1): 24–25.

https://doi.org/10.1182/blood-2020-141751

Published: 2020

Journal Articles

Phase 1 Trial of Vodobatinib, a Novel Oral BCR-ABL1 Tyrosine Kinase Inhibitor (TKI): Activity in CML Chronic Phase Patients Failing TKI Therapies Including Ponatinib

Blood (2020) 136 (Supplement 1): 51–52.

https://doi.org/10.1182/blood-2020-139847

Published: 2020

Journal Articles

Comparison of Outcomes of Donor Lymphocyte Infusions with or without Lenalidomide in Patients with Hematological Malignancies Post Allogeneic Transplant

Sachin Punatar, Vinodhini Murugaiyan, Anant Gokarn, MDDM, Akanksha Chichra, DNB, Sumeet Prakash Mirgh, MDDM, Lingaraj Nayak, MD DM, Avinash Bonda, MD DM, Vijay Shirure, MD DM, Bhausaheb Bagal, MD DM, Libin J Mathew, BSc, Sadhana Kannan, MSc, Tapan Saikia, MD, Navin Khattry, MD DM

Blood (2020) 136 (Supplement 1): 28–29.

https://doi.org/10.1182/blood-2020-141898

Published: 2020

Journal Articles

Real World Experience of Etanercept in Steroid Refractory Acute Graft Versus Host Disease from a Tertiary Cancer Centre in India

Akanksha Chichra, DNB, Sachin Punatar, Anant Gokarn, MDDM, Sumeet Prakash Mirgh, MDDM, Vijay Shirure, MD DM, Vinodhini Murugaiyan, Avinash Bonda, MD DM, Lingaraj Nayak, MD DM, Bhausaheb Bagal, MD DM, Sadhana Kannan, MSc, Libin J Mathew, BSc, Tapan Saikia, MD, Navin Khattry, MD DM

Blood (2020) 136 (Supplement 1): 2–3.

https://doi.org/10.1182/blood-2020-141920

Published: 2020

Journal Articles

Efficacy of Artesunate for Treatment of Cytomegalovirus Reactivations in Allogeneic Haematopoietic Stem Cell Transplant Recipients Who Are Intolerant/Unsuitable for Ganciclovir Therapy

Ramnath K Shenoy, MD, Anant Gokarn, MD, Anup Toshniwal, MDDM, Siddhesh Arun Kalantri, MD, Akanksha Chichra, DNB, Sachin Punatar, MBBS,MDDM MDcal Oncology, Avinash Bonda, MD DM, Lingaraj Nayak, MDDM MDcal Oncology, Libin J Mathew, Vivek Bhat, MD, Sanjay Biswas, MD, Rohini Kelkar, MD, Navin Khattry, MD DM MDcal Oncology

Blood (2019) 134 (Supplement_1): 4506.

https://doi.org/10.1182/blood-2019-128766

Published: 2019

Journal Articles

Fludarabine Melphalan Versus Fludarabine Treosulfan As Reduced Intensity Conditioning Regimens in Allogeneic Hematopoietic Stem Cell Transplant - a Retrospective Analysis

Akanksha Chichra, DNB, Lingaraj Nayak, MDDM MDcal Oncology, Rushabh Kothari, MD DM MDcal Oncology, Siddhesh Arun Kalantri, MD, Avinash Bonda, MD DM, Anant Gokarn, MD, Sachin Punatar, MBBS,MDDM MDcal Oncology, Bhausaheb Bagal, MD DM, Sadhana Kannan, MSc, Libin J Mathew, Navin Khattry, MD DM MDcal Oncology

Blood (2019) 134 (Supplement_1): 4493.

https://doi.org/10.1182/blood-2019-128099

Published: 2019

Journal Articles

A Novel Machine Learning Derived Genomics-Based Scoring System Is Highly Predictive of Outcome in Core Binding Factor Acute Myeloid Leukemia

Nikhil Patkar, MD, Chinmayee Kakirde, Anam Fatima Shaikh, Shrinidhi Nathany, MD, Gaurav Chatterjee, MD, Prashant Tembhare, MD, Dhanlaxmi Lalit Shetty, PhD, Anant Gokarn, MD, Sachin Punatar, MBBS,MDDM MDcal Oncology, Avinash Bonda, MD DM, Lingaraj Nayak, MDDM MDcal Oncology, Hasmukh Jain, MD DM, Navin Khattry, MD DM MDcal Oncology, Bhausaheb Bagal, MD DM, Manju Sengar, MD DM, Sumeet Gujral, MD, Papagudi Ganesan Subramanian, MD

Blood (2019) 134 (Supplement_1): 2710.

https://doi.org/10.1182/blood-2019-128500

Published: 2019

Journal Articles

Pre-Transplant Use of Tyrosine Kinase Inhibitors Increases Risk of Transplant Associated Thrombotic Microangiopathy - a Single Centre Analysis of Incidence, Risk Factors and Outcomes

Siddhesh Arun Kalantri, MD, Akanksha Chichra, DNB, Amit Kumar Agrawal, MDMDcine, Lingaraj Nayak, MDDM MDcal Oncology, Avinash Bonda, MD DM, Sachin Punatar, MBBS,MDDM MDcal Oncology, Anant Gokarn, MD, Bhausaheb Bagal, MD DM, Libin J Mathew, Sadhana Kannan, MSc, Navin Khattry, MD DM MDcal Oncology

Blood (2019) 134 (Supplement_1): 1983.

https://doi.org/10.1182/blood-2019-125029

Published: 2019

Journal Articles

Phase 1 Trial of K0706, a Novel Oral BCR-ABL1 Tyrosine Kinase Inhibitor (TKI): In Patients with Chronic Myelogenous Leukemia (CML) and Phildelphia Positive Acute Lymphoblastic Leukemia (Ph+ ALL) Failing ≥ 3 Prior TKI Therapies: Initial Safety and Efficacy

Blood (2019) 134 (Supplement_1): 4158.

https://doi.org/10.1182/blood-2019-129751

Published: 2019

Journal Articles

Immunophenotypic Assessment of Minimal Residual Disease in Younger Acute Myeloid Leukemia Patients Is Highly Predictive of Outcome

Blood (2018) 132 (Supplement 1): 1498.

https://doi.org/10.1182/blood-2018-99-116837

Published: 2018

Journal Articles

Bortezomib in Combination with Cyclophosphamide and G-CSF for Hematopoietic Stem Cell Mobilization in Patients with Multiple Myeloma

Bhausaheb Bagal, MD DM, Anant Gokarn, MD DM, Avinash Bonda, MD DM, Swapnil Chavan, BSc, Sachin Punatar, MD DM, Lingaraj Nayak, MBBS, MD DM, Sadhana Kannan, MSc, Libin J Mathew, BSc, Nikhil Patkar, MD, Prashant Tembhare, MD, Minal Poojary, Shashank Ojha, Papagudi Ganesan Subramanian, MD, Sumeet Gujral, MD, Tapan Saikia, MD, Navin Khattry, MD DM

Blood (2018) 132 (Supplement 1): 2067.

https://doi.org/10.1182/blood-2018-99-116886

Published: 2018

Journal Articles

Modulation of Donor Graft By the Steroidal Lactone Withaferin A Alleviates Post-Transplant Acute GVHD Via Nrf-2 Independent T-Reg Induction

Vikram Gota, MD, Miten Mehta, PhD, Dievya Gohil, MSc, Dhruv Jha, M.Pharm, Rajiv Kumar, MBBS, MD DM, Beamon Agarwal, MD PhD, Deepak Sharma, PhD, Santosh Sandur, PhD, Navin Khattry, MD DM, Anuradha Majumdar, PhD

Blood (2017) 130 (Supplement 1): 3174.

https://doi.org/10.1182/blood.V130.Suppl_1.3174.3174

Published: 2017

Journal Articles

Over-Expression of ERG Predicts Poor Outcome in Acute Myeloid Leukemia

Syed Khizer Hasan, PhD, Nikhil Patkar, MD, Devanand Vishwakarma, MSc, Deepan Rajamanickam, MD, Anant Gokarn, MD, Arvind Sahu, MD, Prashant Tembhare, MD, Sadhana Kannan, MSc, Sumeet Gujral, MD, Bhausaheb Bagal, MD DM, Hasmukh Jain, MD, Hari Menon, MD, Manju Sengar, MD DM, Pratibha Kadam Amare, PhD, Papagudi Ganesan Subramanian, MD, Navin Khattry, MD DM

Blood (2017) 130 (Supplement 1): 3920.

https://doi.org/10.1182/blood.V130.Suppl_1.3920.3920

Published: 2017

Journal Articles

Use of Leflunomide for Treatment of Cytomegalovirus Infection in Recipients of Allogeneic Stem Cell Transplant

Anant Gokarn, MD, Anup Toshniwal, MD, Amogh Pathak, MBBS, Sankalp Arora, MBBS, Avinash Bonda, MD DM, Pankaj Dwivedi, MD, Sachin Punatar, MD DM, Vivek Bhat, MD, Sanjay Biswas, MD, Rohini Kelkar, MD, Tapan Saikia, MD, Sadhana Kannan, MSc, Navin Khattry, MD DM

Blood (2017) 130 (Supplement 1): 1945.

https://doi.org/10.1182/blood.V130.Suppl_1.1945.1945

Published: 2017

Journal Articles

Presence of Minimal Residual Disease at End of Induction in Acute Myeloid Leukemia Is Predictive of Poor Outcome

Blood (2017) 130 (Supplement 1): 5109.

https://doi.org/10.1182/blood.V130.Suppl_1.5109.5109

Published: 2017

Journal Articles

Impact of Surveillance Stool Culture Guided Selection of Antibiotics in Allogeneic Hematopoietic Stem Cell Transplant Patients

Davinder Paul, MD, Anant Ganesh Gokarn, MD DM, Vasudev Bhat, MD, Vivek Bhat, MD, Avinash Bonda, MD, Saurabh Zanwar, MD, Libin Mathew, Sadhana Kannan, Deepa Susan, MD DM, Tapan Saikia, MD, Navin Khattry, MD DM

Blood (2016) 128 (22): 3389.

https://doi.org/10.1182/blood.V128.22.3389.3389

Published: 2016

Journal Articles

A Retrospective Cohort Study to Evaluate the Outcomes of HIV-Associated High-Grade B-Cell Non-Hodgkin Lymphoma (NHL) Treated with Dose Adjusted R EPOCH Regimen

Hasmukh Jain, Manju Sengar, Hari Menon, MD DM, Tanuja Shet, MD, Epari Sridhar, MD Pathology, Bhausaheb Bagal, MD DM, Siddhartha Laskar, MD Radiation Oncology, Sumeet Gujral, MD, Navin Khattry, MD DM, Archi Agarwal, Nuclear MD cine, Deepa SUSAN Philip, MD

Blood (2016) 128 (22): 4213.

https://doi.org/10.1182/blood.V128.22.4213.4213

Published: 2016

Journal Articles

Minimal Residual Disease in Acute Myeloid Leukemia Using a Difference from Normal Approach Is Predictive of Outcome

Chinmayee Kakirde, Rohan Kodgule, Goutham Raval, Sanjay Talole, Shraddha Kadechkar, Gaurav Chatterjee, Badrinath Yajamanam, Sitaram Ghoghale, Nilesh Deshpande, Pratibha Amare Kadam, PhD, Hari Menon, MD DM., Manju Sengar, Navin Khattry, MD DM, Hasmukh Jain, Bhausaheb Bagal, MD DM, Prashant Tembhare, MD, Sumeet Gujral, MD, Nikhil Patkar, MD

Blood (2016) 128 (22): 5249.

https://doi.org/10.1182/blood.V128.22.5249.5249

Published: 2016

Journal Articles

Plasmacytoid Dendritic Cell Levels at End of Induction Are Predictive of MRD Clearance and Also Influence Disease Outcome in a Subset of Patients

Papagudi Ganesan Subramanian, MD, Nikhil Patkar, MD, Prashant Tembhare, MD, Yajamanam Badrinath, Sitaram Ghoghale, Sumeet Gujral, MD, Hari Menon, MD DM, Hasmukh Jain, Bhausaheb Bagal, MD DM, Manju Sengar, Navin Khattry, MD DM

Blood (2016) 128 (22): 5263.

https://doi.org/10.1182/blood.V128.22.5263.5263

Published: 2016

NARROW

Molecular Measurable Residual Disease Detection in Acute Myeloid Leukemia Using Error Corrected Next Generation Sequencing

Incidence, Risk Factors, and Outcomes of Viral Reactivations in Alternative Donor Haematopoietic Stem Cell Transplant

Phase 1 Trial of Vodobatinib, a Novel Oral BCR-ABL1 Tyrosine Kinase Inhibitor (TKI): Activity in CML Chronic Phase Patients Failing TKI Therapies Including Ponatinib

Comparison of Outcomes of Donor Lymphocyte Infusions with or without Lenalidomide in Patients with Hematological Malignancies Post Allogeneic Transplant

Real World Experience of Etanercept in Steroid Refractory Acute Graft Versus Host Disease from a Tertiary Cancer Centre in India

Efficacy of Artesunate for Treatment of Cytomegalovirus Reactivations in Allogeneic Haematopoietic Stem Cell Transplant Recipients Who Are Intolerant/Unsuitable for Ganciclovir Therapy

Fludarabine Melphalan Versus Fludarabine Treosulfan As Reduced Intensity Conditioning Regimens in Allogeneic Hematopoietic Stem Cell Transplant - a Retrospective Analysis

A Novel Machine Learning Derived Genomics-Based Scoring System Is Highly Predictive of Outcome in Core Binding Factor Acute Myeloid Leukemia

Pre-Transplant Use of Tyrosine Kinase Inhibitors Increases Risk of Transplant Associated Thrombotic Microangiopathy - a Single Centre Analysis of Incidence, Risk Factors and Outcomes

Phase 1 Trial of K0706, a Novel Oral BCR-ABL1 Tyrosine Kinase Inhibitor (TKI): In Patients with Chronic Myelogenous Leukemia (CML) and Phildelphia Positive Acute Lymphoblastic Leukemia (Ph+ ALL) Failing ≥ 3 Prior TKI Therapies: Initial Safety and Efficacy

Immunophenotypic Assessment of Minimal Residual Disease in Younger Acute Myeloid Leukemia Patients Is Highly Predictive of Outcome

Bortezomib in Combination with Cyclophosphamide and G-CSF for Hematopoietic Stem Cell Mobilization in Patients with Multiple Myeloma

Modulation of Donor Graft By the Steroidal Lactone Withaferin A Alleviates Post-Transplant Acute GVHD Via Nrf-2 Independent T-Reg Induction

Over-Expression of ERG Predicts Poor Outcome in Acute Myeloid Leukemia

Use of Leflunomide for Treatment of Cytomegalovirus Infection in Recipients of Allogeneic Stem Cell Transplant

Presence of Minimal Residual Disease at End of Induction in Acute Myeloid Leukemia Is Predictive of Poor Outcome

Impact of Surveillance Stool Culture Guided Selection of Antibiotics in Allogeneic Hematopoietic Stem Cell Transplant Patients

A Retrospective Cohort Study to Evaluate the Outcomes of HIV-Associated High-Grade B-Cell Non-Hodgkin Lymphoma (NHL) Treated with Dose Adjusted R EPOCH Regimen

Minimal Residual Disease in Acute Myeloid Leukemia Using a Difference from Normal Approach Is Predictive of Outcome

Plasmacytoid Dendritic Cell Levels at End of Induction Are Predictive of MRD Clearance and Also Influence Disease Outcome in a Subset of Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only